clinical prediction rule predict quality vitamin k antagonist anticoagulation therapy measured time therapeutic inr range ttr vka eg suggested aid medical decision making vkas new oral anticoagulantnonvka oral anticoagulant noac eg dabigatran rivaroxaban apixaban edoxaban patients atrial fibrillation score used patients additional stroke risk factors using score oral anticoagulation recommended score reflects need offer improved patient care pathway using oral anticoagulants noacs avoid need drug monitoring eg inr monitoring unstable bioavailability indicated patients chronic kidney patients valvular replacement newly diagnosed nonanticoagulated af patient physician may avoid trial warfarin may expose patients increased stroke risk initial inception phase suboptimal anticoagulation make informed decision patients likely well vka score vka perhaps likely associated poor quality anticoagulation control using table add together points assigned different factors maximum score